ProPhase Labs Inc. (NASDAQ: PRPH) open the trading on January 19, 2021, with a bit cautious approach as it glided -25.44% to $11.93. During the day, the stock rose to $12.65 and sunk to $11.60 before settling in for the price of $16.00 at the close. Taking a more long-term approach, PRPH posted a 52-week range of $1.20-$16.04.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -14.90%. Meanwhile, its Annual Earning per share during the time was 10.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -95.00%. This publicly-traded company’s shares outstanding now amounts to $11.60 million, simultaneously with a float of $8.79 million. The organization now has a market capitalization sitting at $138.39 million. At the time of writing, stock’s 50-day Moving Average stood at $10.32, while the 200-day Moving Average is $4.70.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 48 employees. It has generated 205,750 per worker during the last fiscal year. Meanwhile, its income per employee was -64,708. The stock had 1.35 Receivables turnover and 0.60 Total Asset turnover. For the Profitability, stocks gross margin was +26.48, operating margin was -32.80 and Pretax Margin of -31.45.
ProPhase Labs Inc. (PRPH) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. ProPhase Labs Inc.’s current insider ownership accounts for 23.20%, in contrast to 4.20% institutional ownership. According to the most recent insider trade that took place on Aug 13, this organization’s Director bought 50,000 shares at the rate of 2.75, making the entire transaction reach 137,500 in total value, affecting insider ownership by 273,840. Preceding that transaction, on Aug 13, Company’s CEO & CHAIRMAN sold 50,000 for 2.75, making the whole transaction’s value amount to 137,500. This particular insider is now the holder of 2,419,528 in total.
ProPhase Labs Inc. (PRPH) Earnings and Revenue Records
This company achieved a net margin of -31.45 while generating a return on equity of -22.40. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
ProPhase Labs Inc.’s EPS decrease for this current 12-month fiscal period is -95.00% and is forecasted to reach 2.25 in the upcoming year.
ProPhase Labs Inc. (NASDAQ: PRPH) Trading Performance Indicators
Let’s observe the current performance indicators for ProPhase Labs Inc. (PRPH). It’s Quick Ratio in the last reported quarter now stands at 7.40. The Stock has managed to achieve an average true range (ATR) of 1.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.07. Similarly, its price to free cash flow for trailing twelve months is now 276.78.
In the same vein, PRPH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.15, a figure that is expected to reach 0.00 in the next quarter, and analysts are predicting that it will be 2.25 at the market close of one year from today.
Technical Analysis of ProPhase Labs Inc. (PRPH)
[ProPhase Labs Inc., PRPH] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 73.19% While, its Average True Range was 1.55.
Raw Stochastic average of ProPhase Labs Inc. (PRPH) in the period of the previous 100 days is set at 69.45%, which indicates a major rise in contrast to 43.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 171.64% that was higher than 155.71% volatility it exhibited in the past 100-days period.